0.00Open0.00Pre Close0 Volume0 Open Interest130.00Strike Price0.00Turnover94.33%IV-41.47%PremiumJan 17, 2025Expiry Date38.11Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9129Delta0.0080Gamma2.37Leverage Ratio-0.0637Theta-0.0483Rho-2.17Eff Leverage0.0364Vega
Champion Homes Stock Discussion
$Champion Homes (SKY.US)$ $Cavco Industries (CVCO.US)$ $Berkshire Hathaway-B (BRK.B.US)$
• $Allegiance (ABTX.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge (BG.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence (CRNC.US)$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares (FMBH.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co (LAMR.US)$ : Citigroup Up...
• $SpringWorks Therapeutics (SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences (ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen (OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Champion Homes (SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase (NTES.US)$ +4.1% (In...
No comment yet